Table 2 A summary table of the advantages and disadvantages of clinical, radiological and microbiological assessment tools for the diagnosis of VAP

From: Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges

 

Advantages

Disadvantages

Bedside Clinical Symptoms

•Inexpensive

•Rapid, bedside assessment

•Any clinician/grade

•Foundation of clinical suspicion

•Nonspecific to the cause of infection

•Overlap with many disease processes

•Confounded by ICU imposed factors

•Inconclusive

Radiological Diagnosis

CT

•3D imaging

•High resolution of different densities

•Accurate

•Radiation risk

•Transfer risks

•Time delay

•Cost

CXR

•Portable enabling a bedside assessment

•Rapid

•Pragmatic

•Inexpensive

•2D imaging only

•Patient positioning limited

•Difficult interpretation

•Overlap with many disease processes

•Benefits from comparison images

Lung Ultrasound

•Portable enabling a bedside assessment

•Rapid

•Inexpensive

•Minimal radiation

•Dynamic exploration

•Specialist training

•Limitations include body habitus and subcutaneous emphysema

•Not a recognised or validated assessment tool

Microbiological Diagnosis

Non-invasive techniques

•Simple

•Safe

•Rapid/efficient to obtain a sample

•Obtained by a breadth of ICU staff groups

•Does not require extensive training

•Cross-contamination risk

•Unable to isolate lower respiratory tract

Invasive techniques

•Targets the lower respiratory tract, therefore, more specific

•Not routinely available over 24 h

•Requires specialist training

•Risk of patient instability

Qualitative techniques

•Simple

•Quicker and more efficient than quantitative methods

•Not specific to the exact organism

Quantitative techniques

•Specific

•Allows for targeted antibiotic therapy

•Timely

•Costly

•Laboratory resources

•Expertise required

  1. When diagnosing CAP, numerous scoring tools insist, including the PSI (pneumonia severity index)163, CURB-65 (confusion; urea > 7 mM; respiratory rate ≥ 30 breaths·min−1; blood pressure < 90 mmHg systolic or ≤ 60 mmHg diastolic; aged ≥ 65 years old)164 and the mATS (modified American Thoracic Society rule)165. Each is considered useful for predicting the need for intensive care unit treatment and mortality associated with pneumonia; however, their use in VAP diagnosis is not supported166.